644 filings
Page 3 of 33
8-K
joe6k951 pxfcf3
4 May 23
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance
7:15am
8-K
4q7mejnyvpl95waerqk
4 May 23
Departure of Directors or Certain Officers
7:10am
8-K
5o5h ztrasz31
7 Mar 23
Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
7:15am
8-K
vfeqw
1 Mar 23
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
4:15pm
8-K
bqcd0ww5se 2gt6k4l
1 Feb 23
Other Events
9:00am
8-K
6dqfrnz r0i
9 Jan 23
Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer
8:15am
8-K
lq8uikn7 uvhx6u
3 Nov 22
Xtant Medical Announces Third Quarter 2022 Financial Results
7:05am
S-8
j9c bpj5ib41dj
28 Oct 22
Registration of securities for employees
4:26pm
8-K
tbe0n3 sexp1
28 Oct 22
Departure of Directors or Certain Officers
4:15pm
EFFECT
hkk1fm8578oqw2 cey
21 Oct 22
Notice of effectiveness
12:15am
424B3
kurzhvwaipwi8fc
20 Oct 22
Prospectus supplement
5:24pm
CORRESP
4aj ellx4nmpdqlk
18 Oct 22
Correspondence with SEC
12:00am
UPLOAD
ok88o7i7qxk rg0ii5nd
17 Oct 22
Letter from SEC
12:00am
8-K
5a0ogvo
11 Oct 22
Xtant Medical Announces Closing of Second Tranche of $9.75 Million Private Investment
8:15am
DEF 14C
ei4 7sphk9
9 Sep 22
Information statement
6:30am
8-K
i8bu8ta
31 Aug 22
Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment
8:15am